Canis ISSN: 2398-2942

Ephedrine

Synonym(s): Ephedrine sulphate, Ephedrine hydrochloride, Enurace

Contributor(s): Vetstream Ltd, Gigi Davidson

Introduction

Name

  • Ephedrine.

Class of drug

  • Sympathomimetic alkaloid.
  • Mixed alpha- and beta-adrenergic agonist, by causing the release of norepinephrine.

Description

Chemical name

  • (R*,S*)-2-(methylamino)-1-phenylpropan-1-ol.

Molecular formula

  • C10H15NO.

Molecular weight

  • 165.23 g.

Physical properties

  • Fine, odorless, white crystals or powder.
  • Approximately 770 mg are soluble in 1 mL of water.
  • Colorless aqueous solution.

Storage requirements

  • Room temperature.
  • Protect from light.
Considered a controlled substance in the US due to use in methamphetamine manufacturing.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

Polyuria should be excluded before treatment is given for urinary incontinence, as many conditions that cause polyuria would be exacerbated by ephedrine.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

With other drugs

  • Should not be used with other sympathomimetic agents or monoamine oxidase inhibitors, eg selegeline Selegeline hydrochloride.
  • Volatile anesthetics will enhance the sensitivity of the myocardium to the effects of ephedrine.
  • Concomitant use with cardiac glycosides (digoxin Digoxin) and tricyclic antidepressants (amitriptyline Amitriptyline) can cause arhythmias.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed Papers

Other sources of information

  • Ramsey I (2017) BSAVA Small Animal Formulary. 9th edn. British Small Animal Association. pp 141.
  • Plumb D (2015) Plumb's Veterinary Drug Handbook. 8th edn. Wiley-Blackwell. pp 1296.
  • Ko J (2009) Anesthesia Monitoring Techniques and Management. Proceedings of the Atlantic Coast Veterinary Conference.
  • Peck T E, Hill S A & Williams M (2005) Sympathomimetics. In: Pharmacology for Anaesthesia and Intensive Care. Greenwich Medical Media, London, UK. pp 187-208.

ADDED